1. Home
  2. FLXS vs GANX Comparison

FLXS vs GANX Comparison

Compare FLXS & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flexsteel Industries Inc.

FLXS

Flexsteel Industries Inc.

HOLD

Current Price

$40.70

Market Cap

184.8M

ML Signal

HOLD

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$2.44

Market Cap

159.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLXS
GANX
Founded
2001
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
184.8M
159.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FLXS
GANX
Price
$40.70
$2.44
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.00
AVG Volume (30 Days)
27.6K
2.2M
Earning Date
02-02-2026
11-12-2025
Dividend Yield
2.05%
N/A
EPS Growth
64.53
N/A
EPS
4.11
N/A
Revenue
$447,505,000.00
N/A
Revenue This Year
$4.11
N/A
Revenue Next Year
$3.04
N/A
P/E Ratio
$9.47
N/A
Revenue Growth
6.00
N/A
52 Week Low
$29.38
$1.41
52 Week High
$64.14
$4.34

Technical Indicators

Market Signals
Indicator
FLXS
GANX
Relative Strength Index (RSI) 51.31 38.50
Support Level $38.57 $2.30
Resistance Level $41.43 $3.29
Average True Range (ATR) 1.43 0.48
MACD -0.22 -0.13
Stochastic Oscillator 43.65 19.33

Price Performance

Historical Comparison
FLXS
GANX

About FLXS Flexsteel Industries Inc.

Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: